Asian Spectator

ACN Newswire Business

Jacobson Pharma's Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited

  • Written by ACN Newswire - Press Releases

Jacobson Pharma's Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited

HONG KONG, Jan 15, 2021 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced the declaration of a conditional special interim dividend by way of a distribution in specie of an aggregate of 241,777,625 JBM Shares, representing approximately 27.1% of the total number of JBM Shares in issue immediately upon completion of the proposed spin-off, to the qualifying shareholders.

As of today, the total number of issued shares of the Company ("Shares") is 1,934,221,000. Assuming there is no change in the total number of shares from today up to 29 January 2021 (the "Record Date"), the qualifying shareholders will receive one JBM Share for every eight Shares held on the Record Date.

The distribution is conditional on the public offer becoming unconditional in all respects. If such condition is not satisfied, the proposed spin-off will not take place and the distribution will not be made.

For more details, please refer to the link of announcement: https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0115/2021011501333.pdf

About Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is a leading generic drug company in Hong Kong. The Group also carries a portfolio of proprietary brands, notably Po Chai Pills, Ho Chai Kung TjiThung San, Contractubex Scar Gel, Flying Eagle Woodlok Oil, Tong Tai Chung Woodlok Oil, Doan's Ointment, Saplingtan, Shiling Oil and Col-gan Tablet, which have been widely recognised by the market. In the strategic expansion of its branded healthcare business platform, the Group has introduced health and wellness brands and products such as Dr. Freeman Flu/RSV Combo, SmartfishHealth Nutrition Products, Dr. Freeman Infection Control Product Series and Dr Freeman COVID-19 Rapid Test Kit, among other reputable brands represented in overseas markets such as Excilor and Weisen-U.

The Group aims at the continued strategic enrichment of both of its generic drug and branded healthcare portfolios through the addition of high value-added products. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan, Singapore and Cambodia forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com

For media enquiries, please contact:Strategic Financial Relations LimitedVicky Lee Tel: (852) 2864 4834 Email: vicky.lee@sprg.com.hkRachel Ko Tel: (852) 2114 2370 Email: rachel.ko@sprg.com.hkMandy Wong Tel: (852) 2114 4900 Email: mandy.wong@sprg.com.hkFax: (852) 2527 1196

Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

DAZN Group Announces Appointment Of Kevin Mayer As Chairman Of...

LONDON and NEW YORK, March 3, 2021 /PRNewswire-AsiaNet/ -- - John Skipper to Remain on Board of Directors and Serve as Strategic AdviserDAZN Group, the leading global sports streaming platfo...

Make the Invisible Visible: Catalyst #BiasCorrect For Internat...

NEW YORK, March 4, 2021 /PRNewswire-AsiaNet/ -- -- Campaign Provides Virtual Backgrounds to Call Out Bias inthe WorkplaceNEW YORK, March 3, 2021 /PRNewswire-AsiaNet/ -- Catalyst ( https://c2...

Volocopter Raises EUR 200 Million in Series D Funding Round

BRUCHSAL, Germany, March 3, 2021 /PRNewswire-AsiaNet/ -- - EUR 200 million (USD 240 million) raised in an oversubscribed Series D funding - New investors include funds managed by BlackRock, ...

Founder of NutriBullet(R)* Launches Wellness Brand - Beast Hea...

LOS ANGELES, March 4, 2021 /PRNewswire-AsiaNet/ -- -- Groundbreaking Product is First of Several Planned Launches from Beast Health, LLCColin Sapire, founder of the NutriBullet(R)* and innov...

LMRKTS Completes Successful Proof of Concept Simplifying ISDA...

NEW YORK and LONDON, March 3, 2021 /PRNewswire-AsiaNet/ -- LMRKTS, an industry-leading optimization and compression provider, announced today the successful completion of a proof of concept ...

Fleet Complete Proud Supplier for Team Jumbo-Visma

UTRECHT, Netherlands, March 3, 2021 /PRNewswire-AsiaNet/ -- -- Team Jumbo-Visma will be using Fleet Complete's vehicle tracking technology for its new fleet to gain real-time insights during...

Magazine

Australian startup CareApp receives funding injection to expand app

Australian based startup CareApp has recently raised over $500,000 in funding including $250,000 provided by the South Australian State Government to rapidly expand and scale up their smartphone...

Shaparency launches to enable businesses to go fully digital

New venture developed for post-Covid-19 corporate landscape London-based start-up Shaparency, which has been established in response to the business conditions resulting from Covid-19, announces ...

Specops Significant Cyber Attacks

The prevalence and severity of cyber attacks are increasing at an alarming rate every year. So much so, that statistics from Cybersecurity Ventures estimate that cybercrime will cost the global ...

Writers Wanted



News Co Media

Content & Technology Connecting Global Audiences

More Information - Less Opinion